Cepmed Activities
Cepmed’s efforts to promote personalized medicine include multiple outreach programs and collaborative efforts.
Public-Private Partnerships and Research
Cepmed supports high-impact research intended to advance personalized medicine technology and the adoption of personalized medicine. Our impact is measured financially and socially, through the private funds we attract in our public-private partnerships, through changes in policy, health-care provider behaviour, as well as through overall health outcomes and costs savings to the Canadian healthcare system.
Commercialization of Technology Platforms
Cepmed promotes the commercialization of high-value services and products from three key technology platforms at the Montreal Heart Institute: the Montreal Heart Institute Biobank, the Beaulieu-Saucier Pharmacogenomics Centre, and the Montreal Health Innovations Coordinating Centre.
Knowledge Translation
Although the benefits of personalized medicine have been proven in several examples, the adoption of P4™ Medicine, medicine that is Preventative, Predictive, Personalized and Participative, poses many challenges. To pave the way for its adoption, Cepmed is developing education and promotion programs aimed at empowering health-care workers, patients, policy-makers and regulatory bodies with the knowledge and evidence they need to accelerate adoption.